DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Reuschenbach M. et al.
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.

Cancer 2016;
122: 1425-1433

Download Bibliographical Data

Search in:
Access: